About Us
Genosera is a clinical-stage gene therapy company developing transformative treatments for serious genetic diseases using our proprietary platform designed to enhance safety, durability, and ease of manufacturing.
OUR MISSION & VISION
Genosera is revolutionizing the way diseases are treated. Founded in 2019, our mission is to develop cutting-edge gene therapy treatments for rare diseases and difficult disease applications.
We believe that gene therapy is the key to unlocking better healthcare, and our team of experts is dedicated to developing safe, effective, and affordable treatments. We are passionate about our work and strive to make a positive difference in the lives of people from around the world inflicted with disease.
MANAGEMENT TEAM
20+ years of translational research in AAV Gene therapies. 30+ years as scientific researcher, multiple INDs
15+ years in medical research and clinical practice. 50 State licensed. Board Certified in Medical Genetics/Genomics
30+ yrs. Biotech R&D,
IP/Legal, Venture Capital
​​​
BOARD OF DIRECTORS
Created/funded ~150 technology spin-outs from universities, advisor, Board
​
15+ years in medical research and clinical practice. 50 State licensed. Board Certified in Medical Genetics/Genomics
30+ yrs. Biotech R&D,
IP/Legal, Venture Capital
​​​
SCIENTIFIC ADVISORY BOARD
Robert F. and Edgar T. Wolfe Foundation Endowed Chair in Neuromuscular Research at Nationwide Children’s Hospital, and Professor of Pediatrics and Neurology at The Ohio State University College of Medicine
20+ years of translational research in AAV Gene therapies. 30+ years as scientific researcher, multiple INDs
​​​
Head, Genetics Institute, Soroka Medical Center and Head, Morris Kahn Laboratory of Human Genetics at Ben-Gurion University of the Negev
​